TipRanks
Go Ultimate55% OFF

ETFs with AstraZeneca Pharma India Limited (ASTRAZEN) Exposure

The following ETFs maintain exposure to AstraZeneca Pharma India Limited (IN:ASTRAZEN). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

30 ETFs Hold AstraZeneca Pharma India Limited (ASTRAZEN)

ETFs holding IN:ASTRAZEN
SymbolETF NameAUMExpense Ratio% Weight in ETFMarket Value% Weight in ASTRAZEN
SMINiShares MSCI India Small Cap ETF$679.05M0.74%0.09%$574.51K0.03%
GMFSPDR S&P Emerging Asia Pacific ETF$387.10M0.49%0.07%$288.11K0.02%
SPEMSPDR Portfolio Emerging Markets ETF$16.38B0.07%0.04%$6.26M0.38%
EEMSiShares MSCI Emerging Markets Small Cap ETF$360.61M0.72%0.02%$81.00K<0.01%
EMSMSPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD$599.03M0.55%0.02%$89.80K<0.01%
EMV.BCI WisdomTree Emerging Markets Dividend Index ETF$117.14M0.73%<0.01%$10.73K<0.01%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.21B0.06%<0.01%$1.20M0.07%
DFSEDimensional Emerging Markets Sustainability Core 1 ETF$600.94M0.41%<0.01%$36.90K<0.01%
AVSEAvantis Responsible Emerging Markets Equity ETF$222.20M0.33%<0.01%$13.03K<0.01%
IEMGiShares Core MSCI Emerging Markets ETF$150.34B0.09%<0.01%$6.46M0.39%
SEDMiShares MSCI EM IMI ESG Screened UCITS ETF$1.26B0.18%<0.01%$252.01K0.02%
DFEMDimensional Emerging Markets Core Equity 2 ETF$9.08B0.39%<0.01%$295.59K0.02%
DFAEDimensional Emerging Core Equity Market ETF$9.42B0.29%<0.01%$279.19K0.02%
DEXCDimensional Emerging Markets ex China Core Equity ETF$276.59M0.43%<0.01%$7,869.1<0.01%
VSMLVanguard FTSE Global Small-Cap UCITS ETF Accun USD$44.32M0.25%<0.01%$1,161.96<0.01%
VSMDVanguard Funds plc - Vanguard FTSE Global Small-Cap UCITS ETF$12.34M0.25%<0.01%$1,161.96<0.01%
VWOVanguard FTSE Emerging Markets ETF$119.81B0.06%<0.01%$4.36M0.27%
V3MAVanguard Funds PLC - Vanguard ESG Emerging Markets All Cap UCITS ETF AccumUSD$117.70M0.33%<0.01%$3,163.12<0.01%
V3MLVanguard ESG Emerging Markets All Cap UCITS ETF USD$23.62M0.33%<0.01%$3,163.12<0.01%
XEC.UiShares Core MSCI Emerging Markets IMI Index ETF Trust Units$16.83M0.30%<0.01%$83.65K<0.01%
XECiShr Core EmrgMktIMI$4.62B0.30%<0.01%$83.65K<0.01%
SPGMSPDR Portfolio MSCI Global Stock Market ETF$1.82B0.09%<0.01%$27.77K<0.01%
VSGXVanguard ESG International Stock ETF$6.61B0.10%<0.01%$62.16K<0.01%
DFAXDimensional World ex U.S. Core Equity 2 ETF$12.19B0.28%<0.01%$89.40K<0.01%
VXUSVanguard Total International Stock ETF$163.15B0.05%<0.01%$4.72M0.29%
V3ALVanguard ESG Global All CapUCITS ETF USD$638.31M0.26%<0.01%$8,133.74<0.01%
V3AAVanguard ESG Global All CapUCITS ETF AccumUSD$1.28B0.26%<0.01%$8,133.74<0.01%
VTVanguard Total World Stock ETF$84.28B0.06%<0.01%$249.84K0.02%
AVEMAvantis Emerging Markets Equity ETF$27.48B0.33%<0.01%$21.70K<0.01%
AVXCAvantis Emerging Markets ex-China Equity ETF$440.92M0.33%<0.01%$330.75<0.01%
Find ETFs with the TipRanks ETF screener

Popular ETFs

Popular ETFs
CompanyPrice & ChangeFollow
SPYSPDR S&P 500 ETF Trust―
QQQInvesco QQQ Trust―
DIASPDR Dow Jones Industrial Average ETF Trust―
IWMiShares Russell 2000 ETF―
VOOVanguard S&P 500 ETF―

ASTRAZEN ETF Exposure FAQ

What ETFs hold AstraZeneca Pharma India Limited stock?
AstraZeneca Pharma India Limited (IN:ASTRAZEN) is currently held by 30 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to IN:ASTRAZEN include iShares (IEMG), State Street (SPEM) and Vanguard (VSS).
Which ETF has the largest exposure to IN:ASTRAZEN?
The ETF with the largest exposure to IN:ASTRAZEN is iShares (IEMG), with approximately INR 6.46M in market value exposure.
How much IN:ASTRAZEN stock is held by ETFs?
ETFs currently hold approximately INR 15.02M worth of AstraZeneca Pharma India Limited (IN:ASTRAZEN) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.